Table 6 Laboratory data of post-transplant visceral leishmaniasis patients in remission and up to 6 months post-transplantation

Creatinine (mg/dL)

0.002

 1^st evaluation

1.81 (0.4)

 2^nd evaluation

2.21 (0.46)

 3^rd evaluation

1.9 (1.17)

 90 days post-treatment

1.77 (0.27)

 180 days post-treatment

1.80 (0.33)

Urea (mg/dL)

0.000

 1^st evaluation

105.13 (16.91)

 2^nd evaluation

97.80 (15.89)

 3^rd evaluation

65.13 (27.18)

 90 days post-treatment

63.40 (20.40)

 180 days post-treatment

52.07 (9.98)

Hematocrit (%)

0.000

 1^st evaluation

28.72 (4.18)

 2^nd evaluation

29.72 (3.65)

 3^rd evaluation

34.94 (3.50)

 90 days post-treatment

37.73 (2.57)

 180 days post-treatment

38.76 (1.72)

Leukocytes (mm³/dL)

0.000

 1^st evaluation

3.07 (1.05)

 2^nd evaluation

4.51 (3.27)

 3^rd evaluation

5.86 (2.71)

 90 days post-treatment

6.18 (1.41)

 180 days post-treatment

6.40 (0.95)

Platelets (mm³/dL)

0.000

 1^st evaluation

110.33 (88.18)

 2^nd evaluation

178.07 (183.17)

 3^rd evaluation

163.00 (72.02)

 90 days post-treatment

177.00 (18.13)

 180 days post-treatment

183.07 (11.88)

Serum albumin (mg/dL)^†

0.009

 1^st evaluation

3.32 (0.76)

 2^nd evaluation

3.74 (0.37)

 90 days post-treatment

3.87 (0.34)

 180 days post-treatment

3.99 (0.27)